Cyclerion Therapeutics (CYCN) Exchange Rate Effect (2019 - 2024)
Cyclerion Therapeutics (CYCN) recorded quarterly Exchange Rate Effect of -$2000.0 in Q2 2024, up 50.0% quarter-over-quarter from -$4000.0 in Q1 2024, and down 166.67% on a YoY basis from $3000.0 in Q3 2023.
Cyclerion Therapeutics (CYCN) Exchange Rate Effect (2019 - 2024) Analysis & Trends
Cyclerion Therapeutics' Exchange Rate Effect history runs 6 years deep, the most recent figure standing at -$2000.0 for Q2 2024.
- In Q2 2024, Exchange Rate Effect fell 166.67% year-over-year to -$2000.0; the TTM figure through Mar 2025 stood at -$2000.0 (down 166.67% YoY), while the FY2024 annual figure was -$6000.0, down 175.0% from the prior year.
- Exchange Rate Effect was -$2000.0 for Q2 2024 at Cyclerion Therapeutics, up from -$4000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $8000.0 in Q4 2022 to a low of -$12000.0 in Q2 2020.
- Historically, Exchange Rate Effect has averaged $142.86 across 5 years, with a median of $1000.0 in 2021.
- The sharpest annual moves came in 2023 and 2024: Exchange Rate Effect soared 400.0% in 2023, then slumped 500.0% in 2024.
- A 5-year view of Exchange Rate Effect shows it stood at $3000.0 in 2020, then changed by 0.0% to $3000.0 in 2021, then soared by 166.67% to $8000.0 in 2022, then tumbled by 50.0% to $4000.0 in 2023, then tumbled by 150.0% to -$2000.0 in 2024.
- The last three Exchange Rate Effect figures came in at -$2000.0 (Q2 2024), -$4000.0 (Q1 2024), and $4000.0 (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FX Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 8.68 Mn |
| 10 | Cyclerion Therapeutics | 11.50 Mn | 8.26 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -2,000.00 |
| Jun 30, 2024 | -2,000.00 |
| Mar 31, 2024 | -4,000.00 |
| Mar 31, 2024 | -4,000.00 |
| Dec 31, 2023 | 4,000.00 |
| Dec 31, 2023 | 4,000.00 |
| Jun 30, 2023 | 3,000.00 |
| Jun 30, 2023 | 3,000.00 |
| Mar 31, 2023 | 1,000.00 |
| Mar 31, 2023 | 1,000.00 |
| Dec 31, 2022 | 8,000.00 |
| Dec 31, 2022 | 8,000.00 |
| Sep 30, 2022 | -3,000.00 |
| Sep 30, 2022 | -3,000.00 |
| Jun 30, 2022 | -1,000.00 |
| Jun 30, 2022 | -1,000.00 |
| Mar 31, 2022 | -1,000.00 |
| Mar 31, 2022 | -1,000.00 |
| Dec 31, 2021 | 3,000.00 |
| Dec 31, 2021 | 3,000.00 |